Product NDC: | 68084-059 |
Proprietary Name: | Zafirlukast |
Non Proprietary Name: | Zafirlukast |
Active Ingredient(s): | 20 mg/1 & nbsp; Zafirlukast |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68084-059 |
Labeler Name: | American Health Packaging |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090372 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130607 |
Package NDC: | 68084-059-21 |
Package Description: | 3 BLISTER PACK in 1 CARTON (68084-059-21) > 10 TABLET, FILM COATED in 1 BLISTER PACK (68084-059-11) |
NDC Code | 68084-059-21 |
Proprietary Name | Zafirlukast |
Package Description | 3 BLISTER PACK in 1 CARTON (68084-059-21) > 10 TABLET, FILM COATED in 1 BLISTER PACK (68084-059-11) |
Product NDC | 68084-059 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Zafirlukast |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20130607 |
Marketing Category Name | ANDA |
Labeler Name | American Health Packaging |
Substance Name | ZAFIRLUKAST |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] |